Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arginine With Whole Brain Radiation Therapy for Brain Metastases
NCT06328686Phase 1Recruiting
- Sponsor
- Emory University
- Start
- Sep 2024
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of arginine in brain metastases (2 arms), sponsored by Emory University. Primary endpoint: Peak plasma L-arginine and arginine metabolite concentration at 4 hours. Started Sep 2024; status: recruiting.
02
Drugs
arginine
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT06328686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06328686.